Safety Patterns over Time with Ozanimod During an Open-label Extension Trial in Patients with Relapsing Multiple Sclerosis

Authors
Category Primary study
JournalNeurology
Year 2024
This article has no abstract
Epistemonikos ID: 40060553f1fc7674df120272086e7e87781883df
First added on: Feb 19, 2025